Early research (Phase 1)Study completedNCT01619033What this trial is testingPharmacokinetics of BF2.649 in Renal ImpairmentWho this might be right forRenal Impairment Bioprojet 25
Early research (Phase 1)Study completedNCT06468826What this trial is testingAvacopan in Participants With Normal Renal Function and Participants With End-Stage Renal Disease (ESRD)Who this might be right forEnd-Stage Renal Disease (ESRD) Amgen 13
Early research (Phase 1)Study completedNCT05497297What this trial is testingEvaluate the Pharmacokinetics of HSK7653 in Subjects With Renal ImpairmentWho this might be right forRenal Impairment Haisco Pharmaceutical Group Co., Ltd. 42
Early research (Phase 1)Not Yet RecruitingNCT07797322What this trial is testingInvestigate the Pharmacokinetics and Safety of PKN605 in Participants With Moderate and Severe Renal Impairment Compared to Matched Control Subjects With Normal Renal FunctionWho this might be right forParticipants With Moderate and Severe Renal Impairment and Healthy Participants Novartis Pharmaceuticals 40
Early research (Phase 1)Study completedNCT04142970What this trial is testingSafety and Pharmacokinetics/Pharmacodynamics of HSK3486 in Patients With Impairment Renal FunctionsWho this might be right forChronic Renal Impairment Sichuan Haisco Pharmaceutical Group Co., Ltd 24
Testing effectiveness (Phase 2)Study completedNCT01569828What this trial is testingMultiple Dose Pharmacokinetics of LCZ696 and Its Metabolites in Subjects With Severe Renal Impairment vs. Matched Healthy Subjects With Normal Renal FunctionWho this might be right forPharmacokineticsRenal ImpairedHealthy Volunteer Novartis Pharmaceuticals 12
Early research (Phase 1)Looking for participantsNCT07141030What this trial is testingStudy of Pharmacokinetics and Safety of GZR18 Injection in Subjects With Renal Impairment and Normal Renal FunctionWho this might be right forObesity/Overweight Gan & Lee Pharmaceuticals. 32
Early research (Phase 1)Study completedNCT01372826What this trial is testingAssessing the Pharmacokinetics of NKTR-118 in Subjects With Renal Impairment Compared to That in Subjects With Normal Renal FunctionWho this might be right forRenal Impairment AstraZeneca 32
Early research (Phase 1)Study completedNCT01901133What this trial is testingHepatic Impairment Study With MDV3100 in Subjects With Mild and Moderate Hepatic Impairment Compared to a Healthy Control GroupWho this might be right forPharmacokinetics of MDV3100Healthy SubjectsKidney Diseases Astellas Pharma Europe B.V. 33
Early research (Phase 1)Study completedNCT03882762What this trial is testingA Clinical Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of CebranopadolWho this might be right forPharmacokinetic Tris Pharma, Inc. 34
Early research (Phase 1)Study completedNCT02508506What this trial is testingPharmacokinetics and Safety of ALKS 5461 in Subjects With Renal Impairment and Normal Renal FunctionWho this might be right forRenal Impairment Alkermes, Inc. 22
Early research (Phase 1)Study completedNCT04859439What this trial is testingEvaluate the Pharmacokinetics and Safety of DBPR108 in Subjects With Renal ImpairmentWho this might be right forRenal Impairment CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 40
Early research (Phase 1)Study completedNCT02182024What this trial is testingPharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate in Patients With and Without Renal ImpairmentWho this might be right forRenal Insufficiency Boehringer Ingelheim 35
Early research (Phase 1)Study completedNCT02096718What this trial is testingAfatinib in Subjects With Kidney DysfunctionWho this might be right forRenal Insufficiency Boehringer Ingelheim 30
Early research (Phase 1)Study completedNCT03506854What this trial is testingStudy of ISIS 681257 in Patients With Renal Impairment Compared to Healthy PatientsWho this might be right forRenal Impairment Akcea Therapeutics 16
Early research (Phase 1)Study completedNCT04935294What this trial is testingStudy of Danicopan in Participants With Normal Kidney Function and Participants With Kidney DysfunctionWho this might be right forHealthyRenal Dysfunction Alexion Pharmaceuticals, Inc. 16
Early research (Phase 1)Study completedNCT03186495What this trial is testingInvestigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Various Degrees of Impaired Renal Function Compared to Subjects With Normal Renal FunctionWho this might be right forGrowth Hormone DisorderAdult Growth Hormone DeficiencyGrowth Hormone Deficiency in Children Novo Nordisk A/S 44
Early research (Phase 1)Study completedNCT00543075What this trial is testingPharmacokinetic Study of Genasense in Subjects With Normal Renal Function, Mildly Impaired Renal Function, and Moderately Impaired Renal FunctionWho this might be right forNormal Renal FunctionMildly Impaired Renal FunctionModerately Impaired Renal Function Genta Incorporated 23
Early research (Phase 1)Study completedNCT02191228What this trial is testingPharmacokinetics, Pharmacodynamics, Safety and Tolerability of Single and Multiple Doses of Linagliptin Tablets in Patients With Different Degrees of Renal Impairment in Comparison to Subjects With Normal Renal FunctionWho this might be right forRenal Insufficiency Boehringer Ingelheim 51
Large-scale testing (Phase 3)Study completedNCT00702715What this trial is testingComparison of 4.0 mg/kg Sugammadex at 1-2 Post Tetanic Counts (PTC) in Renal or Control Patients (19.4.328)(P05769)Who this might be right forAnesthesia Merck Sharp & Dohme LLC 69